日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Implementation of a reference-scaled average bioequivalence approach for highly variable generic drug products by the US Food and Drug Administration

美国食品药品监督管理局对高度可变仿制药产品实施参考标度平均生物等效性方法

Davit, Barbara M; Chen, Mei-Ling; Conner, Dale P; Haidar, Sam H; Kim, Stephanie; Lee, Christina H; Lionberger, Robert A; Makhlouf, Fairouz T; Nwakama, Patrick E; Patel, Devvrat T; Schuirmann, Donald J; Yu, Lawrence X

Highly variable drugs: observations from bioequivalence data submitted to the FDA for new generic drug applications

高度可变药物:从提交给FDA的新仿制药申请的生物等效性数据中得出的观察结果

Davit, Barbara M; Conner, Dale P; Fabian-Fritsch, Beth; Haidar, Sam H; Jiang, Xiaojian; Patel, Devvrat T; Seo, Paul R H; Suh, Keri; Thompson, Christina L; Yu, Lawrence X